MIDRANGE dot COM Mailing List Archive



Home » MIDRANGE-L » June 2003

Re: CL Editor



fixed

the crtclpgm is supposed to be a part of base OS, and not considered a
development compiler. I hope they have not changed that!
jim

----- Original Message -----
From: "Chris Bipes" <chris.bipes@xxxxxxxxxxxxxxx>
To: "'Midrange Systems Technical Discussion'" <midrange-l@xxxxxxxxxxxx>
Sent: Wednesday, June 11, 2003 1:26 PM
Subject: RE: CL Editor


> One thing everyone is missing is that with out WDSc you do not have any
> compilers.  What good is an editor with out a compiler?  All his
development
> work will have to be done on a box that has some sort of compiler, then
the
> program objects shipped over.  Now if it is just some simple CL Scripts,
you
> can do that with a simple Source PF and EDTF using the procedure mentioned
> earlier.
>
>
> -----Original Message-----
> From: Tony Awbrey [mailto:Tony.Awbrey@xxxxxxxxxxxxxxx]
> Sent: Wednesday, June 11, 2003 7:15 AM
> To: midrange-l@xxxxxxxxxxxx
> Subject: Re: CL Editor
>
>
> Ed,
>
> Check out Bob Cozzi's CodeStudio, it is going shareware end of this
> month and looks like it will accomplish what you need to do. I have not
> used it but did look at it awhile back. It has a lot of the same
> functionality as the CODE/400 or WDSc suites.
>
> http://www.rpgiv.com/codestudio
> _______________________________________________
> This is the Midrange Systems Technical Discussion (MIDRANGE-L) mailing
list
> To post a message email: MIDRANGE-L@xxxxxxxxxxxx
> To subscribe, unsubscribe, or change list options,
> visit: http://lists.midrange.com/mailman/listinfo/midrange-l
> or email: MIDRANGE-L-request@xxxxxxxxxxxx
> Before posting, please take a moment to review the archives
> at http://archive.midrange.com/midrange-l.
>
>







Return to Archive home page | Return to MIDRANGE.COM home page

This mailing list archive is Copyright 1997-2014 by MIDRANGE dot COM and David Gibbs as a compilation work. Use of the archive is restricted to research of a business or technical nature. Any other uses are prohibited. Full details are available here. If you have questions about this, please contact